$2.85
-0.0098-0.34%
Pre-Market: 4:32 PM EDT
15 minutes delayed
Comments
Loading...
Aprea Therapeutics (APRE) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAprea Therapeutics (NASDAQ:APRE) Stock Quotes, Forecast and News Summary
Aprea Therapeutics Stock (NASDAQ: APRE) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 9.08K |
| Day Range | - - - |
| 52 Wk Range | 2.86 - 8.85 |
| Market Cap | $15.48M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 32 |
| Short Interest | 0.27% |
| Days to Cover | 2.4 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Aprea Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precis...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aprea Therapeutics (APRE) stock?
You can purchase shares of Aprea Therapeutics (NASDAQ:APRE) through any online brokerage.
Who are Aprea Therapeutics (APRE) competitors?
Other companies in Aprea Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Monopar Therapeutics (NASDAQ:MNPR).
What is the forecast, or price target, for Aprea Therapeutics (APRE) stock?
Aprea Therapeutics has a consensus price target of $10.60.
What is the current price for Aprea Therapeutics (APRE)?
The stock price for Aprea Therapeutics (NASDAQ: APRE) is $2.8502 last updated September 18, 2024 at 4:32 PM EDT.
Does Aprea Therapeutics (APRE) pay a dividend?
There are no upcoming dividends for Aprea Therapeutics.
When is Aprea Therapeutics (NASDAQ:APRE) reporting earnings?
Aprea Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Aprea Therapeutics (APRE) going to split?
There is no upcoming split for Aprea Therapeutics.
What sector and industry does Aprea Therapeutics (APRE) operate in?
Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.